Avita Therapeutics Inc operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Avita Therapeutics Inc with three other
pharmaceutical manufacturers in Australasia:
sales of 5.29 million Australian Dollars [US$3.75 million]
of which 12%
(4.36 million Australian Dollars [US$3.10 million]
Blis Technologies Ltd
based in NEW ZEALAND
(8.41 million New Zealand Dollars [US$5.55 million]
Sales increased substantially in 2019:
During the year ended June of 2019, sales at
Avita Therapeutics Inc were A$8.16 million (US$5.79 million).
increase of 375.1%
versus 2018, when the company's sales were A$1.72 million.
This was the third consecutive year of growth at Avita Therapeutics Inc.
Sales of Operating-Americas. saw an increase
that was more than double the company's growth rate: sales were up
1,271.0% in 2019, from
A$453,299.00 to A$6.21 million.
Not all segments of Avita Therapeutics Inc experienced an increase in sales in 2019:
sales of Operating-Emea. fell 25.5% to A$364,331.00 .